MT-ND4 and pneumocystosis: Our results indicate that CRISPR-mediated Nad4 RNA detection could address this issue, since Nad4 signal was not detected above background in specimens of most individuals not diagnosed with PCP, but had high diagnostic sensitivity (91.7%–100%) for infants infected with P. jirovecii and adults with PCP.